MorphoSys AG American Depositary Shares
MOR was delisted on the 2nd of August, 2024.
27 hedge funds and large institutions have $43.6M invested in MorphoSys AG American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 5 closing their positions.
209% more capital invested
Capital invested by funds: $14.1M → $43.6M (+$29.5M)
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
17% more funds holding
Funds holding: 23 → 27 (+4)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$32.5M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
+$4.02M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$3.47M |
| 4 |
ABG
Ally Bridge Group
New York
|
+$1.39M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$636K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$581K |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$344K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$101K |
| 4 |
ECM
Evergreen Capital Management
Bellevue,
Washington
|
-$52K |
| 5 |
Morgan Stanley
New York
|
-$51.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Barclays
London,
United Kingdom
| $43 | +$54 | +12 | New |
|
|
FGAM
27
Financial Gravity Asset Management
Lakeway,
Texas
| $2 | +$18 | +4 | New |
|
|
ECM
28
Endurant Capital Management
San Mateo,
California
| – | -$344K | -68,290 | Closed |
|
|
29
Citadel Advisors
Miami,
Florida
| – | -$101K | -20,049 | Closed |
|
|
ECM
30
Evergreen Capital Management
Bellevue,
Washington
| – | -$52K | -10,248 | Closed |
|
|
QCG
31
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$4K | -876 | Closed |
|
MOR Hedge Fund Activity: Q4 2022 in Review
27 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q4 2022, worth a combined $43.6M — up 209% from $14.1M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new MOR positions and 5 closed out — a net gain of 4 holders — while 7 added to existing stakes and 7 trimmed.
The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $32.5M. The largest seller was Millennium Management, cutting an estimated $581K.
- 27 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q4 2022, up from 23 in Q3 2022.
- Funds reported $43.6M of MorphoSys AG American Depositary Shares stock for Q4 2022, up 209% quarter-over-quarter.
- 9 funds opened new MorphoSys AG American Depositary Shares positions in Q4 2022 and 5 closed out, a net change of +4 holders.
- The largest MorphoSys AG American Depositary Shares buyer in Q4 2022 was T. Rowe Price Investment Management, an estimated $32.5M added.
- The largest MorphoSys AG American Depositary Shares seller in Q4 2022 was Millennium Management, an estimated $581K sold.
Based on aggregated 13F filings for Q4 2022.